BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10329471)

  • 1. MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation.
    Lee HK; Park UH; Kim EJ; Um SJ
    EMBO J; 2007 Aug; 26(15):3545-57. PubMed ID: 17641689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mollusk retinoic acid receptor (RAR) ortholog sheds light on the evolution of ligand binding.
    Gutierrez-Mazariegos J; Nadendla EK; Lima D; Pierzchalski K; Jones JW; Kane M; Nishikawa J; Hiromori Y; Nakanishi T; Santos MM; Castro LF; Bourguet W; Schubert M; Laudet V
    Endocrinology; 2014 Nov; 155(11):4275-86. PubMed ID: 25116705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis of site-directed mutants of cellular retinoic acid-binding protein II addresses the relationship between structural integrity and ligand binding.
    Vaezeslami S; Jia X; Vasileiou C; Borhan B; Geiger JH
    Acta Crystallogr D Biol Crystallogr; 2008 Dec; 64(Pt 12):1228-39. PubMed ID: 19018099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue.
    Chen W; Dong J; Plate L; Mortenson DE; Brighty GJ; Li S; Liu Y; Galmozzi A; Lee PS; Hulce JJ; Cravatt BF; Saez E; Powers ET; Wilson IA; Sharpless KB; Kelly JW
    J Am Chem Soc; 2016 Jun; 138(23):7353-64. PubMed ID: 27191344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General molecular biology and architecture of nuclear receptors.
    Pawlak M; Lefebvre P; Staels B
    Curr Top Med Chem; 2012; 12(6):486-504. PubMed ID: 22242852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
    Uray IP; Shen Q; Seo HS; Kim H; Lamph WW; Bissonnette RP; Brown PH
    J Biol Chem; 2009 Jan; 284(1):345-353. PubMed ID: 18957410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid.
    Stephen R; Darbre PD
    Br J Cancer; 2000 Nov; 83(9):1183-91. PubMed ID: 11027432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the AP1-antagonism domain of retinoic acid receptors.
    DiSepio D; Sutter M; Johnson AT; Chandraratna RA; Nagpal S
    Mol Cell Biol Res Commun; 1999 Apr; 1(1):7-13. PubMed ID: 10329471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter.
    Benkoussa M; Brand C; Delmotte MH; Formstecher P; Lefebvre P
    Mol Cell Biol; 2002 Jul; 22(13):4522-34. PubMed ID: 12052862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha.
    Nagpal S; Athanikar J; Chandraratna RA
    J Biol Chem; 1995 Jan; 270(2):923-7. PubMed ID: 7822331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
    Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
    EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.